SAEL Industries, Vishvaraj Atmosphere, Symbiotec Pharmalab and three others get Sebi nod to launch IPO

Spread the love

SAEL Industries, Vishvaraj Atmosphere, Symbiotec Pharmalab and three others get Sebi nod to launch IPO

Market regulator Securities and Alternate Board of India (Sebi) has accepted the preliminary public providing (IPO) of six firms. The regulator issued observations on three public points on Friday whereas in accordance its consent to a few others on Wednesday.

Those who obtained Sebi’s permission right now embody Vishvaraj Atmosphere, Shah Investor’s Residence and SAEL Industries. In the meantime, Prasol Chemical compounds, NoPaperForms Options and Symbiotec Pharmalab obtained it on Wednesday, March 25.

In market parlance, an ‘commentary’ is a proper go-ahead by Sebi with feedback on an organization’s draft provide doc.

Jindal Supreme (India) Ltd, which filed its Draft Crimson Herring Prospectus (DRHP) with Sebi, has withdrawn the provide doc, in accordance with a Sebi doc.

Vishvaraj Atmosphere IPO

Vishvaraj Atmosphere IPO plans to boost Rs 2,250 crore from the home major markets. The difficulty is a mixture of a recent fairness issuance and a suggestion on the market (OFS). It’s a main developer of water utility and wastewater administration tasks, specializing in recycling handled sewage water for industries.

The IPO contains a recent subject of as much as Rs 1,250 crore and an OFS aggregating as much as Rs 1,000 crore from the promoter promoting shareholder, Premier Monetary Providers Restricted.
Final week, Sebi cleared the decks for its IPO after the corporate got here beneath regulatory crosshairs.
JM Monetary, Axis Capital Restricted and DAM Capital Advisors Restricted are the E book Working Lead Managers to the problem.

Shah Investor’s Residence IPO

Shah Buyers Residence’s public subject will solely be a recent subject of fairness shares. Beeline Capital Advisors Non-public Restricted is the lead supervisor for the problem.

SIHL is a retail broking agency providing a spread of providers masking fairness and derivatives brokerage, with over three a long time of expertise. These providers facilitate the shopping for and promoting of economic merchandise akin to equities, IPO investing, mutual funds distribution, and different securities. Whereas the corporate’s core operations embody fairness and derivatives brokerage, it additionally focuses on offering secondary market brokering providers to retail prospects, comprising each resident and non-resident Indians.

SAEL Industries IPO

The renewable vitality firm provides decarbonisation options to facilitate India’s adoption of unpolluted and reasonably priced vitality tasks. Its enterprise verticals embody photo voltaic vitality, waste to vitality, module manufacturing and photo voltaic cell manufacturing.

Its Rs 4,575 crore IPO can be a mixture of a recent share issuance and an OFS. The recent subject is price Rs 3,750 crore whereas the OFS is price Rs 825.

The lead supervisor is ICICI Securities Restricted.

Prasol Chemical compounds IPO

The Rs 500 crore IPO can be a mixture of recent fairness and OFS. The recent subject is price Rs 80 crore whereas the OFS is Rs 420 crore.

The lead supervisor is DAM Capital Advisors Restricted.

The corporate operates within the specialty chemical substances business, manufacturing over 150 specialty chemical substances, together with acetone-based, phosphorous-based, and different complicated chemical substances. Its product portfolio consists of 21 acetone-based chemical substances, 53 phosphorous-based chemical substances, and 76 different specialty chemical substances (e.g. surfactants, esters, acids).

NoPaperForms Options IPO

The IPO of NoPaperForms Options can be a mixture of issuance of recent fairness and an OFS. The e-book working lead supervisor (BRLM) is IIFL Capital Providers Restricted.

Based in 2017, NoPaperForms Options provides a unified, vertical SaaS platform for the training sector, with merchandise akin to Meritto and Collexo that assist establishments handle scholar acquisition, lifecycle processes, and funds. The corporate focuses on enhancing income and operational effectivity by way of its know-how options. Headquartered in Delhi, it has additionally expanded its presence past India.

Symbiotec Pharmalab IPO

The Rs 2,180 crore IPO of Symbiotec Pharmalab can be a mixture of recent fairness issuance and an OFS. The e-book working lead supervisor is JM Monetary Restricted. The recent subject measurement can be Rs 150 crore whereas the OFS can be Rs 2,030 crore.

Within the OFS, promoter Satwani Holdings will offload stake together with investor promoting shareholder Rosewood Investments and India Enterprise Excellence Fund –III.

(Disclaimer: The suggestions, ideas, views, and opinions given by the consultants are their very own. These don’t characterize the views of The Financial Instances.)

Leave a Reply

Your email address will not be published. Required fields are marked *